|
Volumn 92, Issue 1, 2002, Pages 246-247
|
Donor-specific transfusion and renal allograft outcome [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIGEN;
AZATHIOPRINE;
CREATININE;
CYCLOSPORIN A;
CYTOTOXIC ANTIBODY;
PREDNISOLONE;
ACUTE DISEASE;
ANTIBODY DETECTION;
BLOOD;
BLOOD DONOR;
BLOOD TRANSFUSION;
CADAVER DONOR;
CHRONICITY;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
DISEASE COURSE;
DISEASE SEVERITY;
GRAFT FAILURE;
GRAFT SURVIVAL;
HEMODIALYSIS;
HLA MATCHING;
HUMAN;
IMMUNOREACTIVITY;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY ALLOGRAFT;
KIDNEY ALLOGRAFT REJECTION;
KIDNEY BIOPSY;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
LETTER;
LEUKOCYTE CULTURE;
LIVING DONOR;
PATIENT CARE;
PREOPERATIVE PERIOD;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
BLOOD TRANSFUSION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
KIDNEY TRANSPLANTATION;
TISSUE DONORS;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
EID: 0036375279
PISSN: 00282766
EISSN: None
Source Type: Journal
DOI: 10.1159/000064449 Document Type: Letter |
Times cited : (4)
|
References (4)
|